Trials / Completed
CompletedNCT00261079
Fexofenadine in Pruritic Skin Disease
The Evaluation of Efficacy and Safety of Fexofenadine 180mg Tablets for 7 Days in the Treatment of Pruritic Skin Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 435 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- 12 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: * To compare the efficacy and safety profile of Fexofenadine 180mg tablets plus prednicarbate(2.5mg/g) vs prednicarbate(2.5mg/g) alone in the treatment of pruritic skin disease Secondary objective: * To evaluate patient's satisfaction of Allegra treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fexofenadine |
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-10-01
- First posted
- 2005-12-02
- Last updated
- 2007-11-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00261079. Inclusion in this directory is not an endorsement.